missiratch biableCtr Drug Evaluat & Res & Oncol Ctr Excellence US FDA关注立即认领分享关注立即认领分享基本信息浏览量:0职业迁徙个人简介暂无内容研究兴趣论文共 2 篇作者统计合作学者相似作者按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选时间引用量主题期刊级别合作者合作机构FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural MesotheliomaErica C Nakajima,Paz J Vellanki,Erin Larkins,Somak Chatterjee,Pallavi S Mishra-Kalyani,Youwei Bi,Hisham Qosa,Jiang Liu,Hong Zhao,Missiratch Biable,Lauren Tesh Hotaki,Yuan-Li Shen,CLINICAL CANCER RESEARCH(2022)引用21浏览0WOS引用210U.S. Food and Drug Administration Approval Summary: Ramucirumab for the Treatment of Metastatic Non-Small Cell Lung Cancer Following Disease Progression On or After Platinum-Based ChemotherapyErin Larkins,Barbara Scepura,Gideon M Blumenthal,Erik Bloomquist,Shenghui Tang,Missiratch Biable,Paul G Kluetz,Patricia Keegan,Richard PazdurONCOLOGIST(2015)引用27浏览0WOS引用270作者统计合作学者合作机构D-Core合作者学生导师暂无相似学者,你可以通过学者研究领域进行搜索筛选数据免责声明页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn